|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_ocn965136875 |
| 003 |
OCoLC |
| 005 |
20231120112159.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
161202s2016 enk o 001 0 eng d |
| 040 |
|
|
|a IDEBK
|b eng
|e pn
|c IDEBK
|d OCLCQ
|d N$T
|d EBLCP
|d IDEBK
|d OPELS
|d YDX
|d MERUC
|d OCLCF
|d N$T
|d OCLCQ
|d OTZ
|d OCLCQ
|d U3W
|d D6H
|d CNCGM
|d OCLCQ
|d S2H
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 964656774
|a 965344764
|a 972594986
|a 972781253
|a 972955353
|a 1004578891
|
| 020 |
|
|
|a 9780128026731
|q (electronic bk.)
|
| 020 |
|
|
|a 0128026731
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128025765
|
| 020 |
|
|
|z 012802576X
|
| 035 |
|
|
|a (OCoLC)965136875
|z (OCoLC)964656774
|z (OCoLC)965344764
|z (OCoLC)972594986
|z (OCoLC)972781253
|z (OCoLC)972955353
|z (OCoLC)1004578891
|
| 050 |
|
4 |
|a RC271.C5
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.99/4061
|2 23
|
| 245 |
0 |
0 |
|a Anti-angiogenesis strategies in cancer therapeutics /
|c edited by Shaker A. Mousa, Paul J. Davis.
|
| 260 |
|
|
|a London :
|b Academic Press is an imprint of Elsevier,
|c 2016.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Includes index.
|
| 588 |
0 |
|
|a Print version record.
|
| 650 |
|
0 |
|a Cancer
|x Chemotherapy.
|
| 650 |
|
6 |
|a Cancer
|x Chimioth�erapie.
|0 (CaQQLa)201-0004691
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Cancer
|x Chemotherapy
|2 fast
|0 (OCoLC)fst00845327
|
| 700 |
1 |
|
|a Mousa, Shaker A.
|
| 700 |
1 |
|
|a Davis, Paul J.
|
| 776 |
0 |
8 |
|i Print version:
|t Anti-angiogenesis strategies in cancer therapeutics.
|d London : Academic Press is an imprint of Elsevier, 2016
|z 9780128025765
|z 012802576X
|w (OCoLC)953708341
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128025765
|z Texto completo
|
